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Abstract
The distribution of lipoprotein(a) [Lp(a)] levels can differ dramatically across diverse racial/ethnic populations. The extent to
which genetic variation in LPA can explain these differences is not fully understood. To explore this, 19 LPA tagSNPs were
genotyped in 7,159 participants from the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III is
a diverse population-based survey with DNA samples linked to hundreds of quantitative traits, including serum Lp(a). Tests
of association between LPA variants and transformed Lp(a) levels were performed across the three different NHANES
subpopulations (non-Hispanic whites, non-Hispanic blacks, and Mexican Americans). At a significance threshold of
p,0.0001, 15 of the 19 SNPs tested were strongly associated with Lp(a) levels in at least one subpopulation, six in at least
two subpopulations, and none in all three subpopulations. In non-Hispanic whites, three variants were associated with Lp(a)
levels, including previously known rs6919246 (p=1.18610
230). Additionally, 12 and 6 variants had significant associations in
non-Hispanic blacks and Mexican Americans, respectively. The additive effects of these associated alleles explained up to
11% of the variance observed for Lp(a) levels in the different racial/ethnic populations. The findings reported here replicate
previous candidate gene and genome-wide association studies for Lp(a) levels in European-descent populations and extend
these findings to other populations. While we demonstrate that LPA is an important contributor to Lp(a) levels regardless of
race/ethnicity, the lack of generalization of associations across all subpopulations suggests that specific LPA variants may be
contributing to the observed Lp(a) between-population variance.
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Introduction
Lipoprotein (a) [Lp(a)] levels have long been recognized as an
independent risk factor for coronary artery disease (CAD)[1–3].
However, Lp(a) concentrations and their relationship with
cardiovascular disease vary across races/ethnicities. The most
notable example of this discrepancy is observed between
populations of European- and African-decent. While the mean
Lp(a) level is two- to threefold higher in blacks relative to
whites[4,5], elevated plasma Lp(a) levels have been reported to be
associated with CAD in whites but have not been clearly
demonstrated in blacks[6–10].
The epidemiology of Lp(a) in other US racial/ethnic popula-
tions, such as Mexican Americans, is not as well documented and
often inconsistent. For example, compared to non-Hispanic
whites, studies have shown Mexican Americans to have both
higher[11] and lower[12] mean Lp(a) levels. The underlying
cause(s) for these between-population differences has not been fully
determined; however, there is evidence for the role of multiple,
population-specific alleles in LPA[13], the gene that encodes for
apolipoprotein(a) [apo(a)], which when bound to apolipoprotein B-
100 and a low density lipoprotein (LDL)-like particle forms Lp(a).
Lp(a) levels not only vary dramatically across populations, they
also have a remarkable inter-individual variability that ranges
from barely detectable to greater than 250 nmol/l[14]. This inter-
individual variability has a substantial genetic component. It has
been determined that the apolipoprotein(a) gene is the major
contributor to Lp(a) levels, accounting for more than 90% of the
variance for that trait in European Americans[15].
Two types of genetic variants in LPA have been associated with
Lp(a) levels: variations in the number of copies of the kringle IV-2
repeat and single nucleotide polymorphisms (SNPs). It has been
estimated that the kringle IV-2 repeat alone explains 61–69% of
the variability observed in Lp(a) levels in populations of European
ancestry[15,16]. In contrast, the kringle repeat appears to explain
less of the variability (19–44%) in populations of African
descent[17–19] and Mexican Americans (22–48%)[20,21]. While
the kringle IV-2 repeat polymorphism accounts for a large
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has yet to be explained.
Recent studies have identified common SNPs in LPA as strongly
associated with Lp(a) levels, explaining up to 36% of the trait
variance in populations of European-descent[22–24]. While
several studies have indicated certain SNPs are in substantial
linkage disequilibrium (LD) with the kringle IV-2 repeat
polymorphism[22,23], evidence also exists that some SNPs are
in relatively little LD with copy number variation in LPA [25] and
may be independent contributors to Lp(a) levels. A recent genome-
wide association study performed in a Hutterite population with
kringle IV-2 repeat polymorphism data identified a SNP
associated with Lp(a) levels independent of the kringle repeat,
supporting the assumption that some common SNPs in LPA are
independent of the kringle repeat polymorphisms (i.e., not in
linkage disequilibrium)[24].
To date, relatively few studies have examined associations
between LPA common SNPs and Lp(a) levels across multiple,
diverse populations and no study has characterized the same panel
of LPA common SNPs in populations of European-, African-, and
Mexican-descent. To better characterize this genotype-phenotype
relationship in more diverse populations, we have genotyped 19
European American and African American LPA tagSNPs in 7,159
participants from the Third National Health and Nutrition
Examination Survey (NHANES III). NHANES III is a diverse,
population-based cohort representing Americans of European-,
African-, and Mexican-descent[26]. We report the significant
association of LPA SNPs and Lp(a) levels in this diverse cohort and
estimate the proportion of Lp(a) variance explained by these
genetic variants.
Results
Population Characteristics
Characteristics of the NHANES III study participants are
shown in Table 1. Genetic NHANES III included 2,631 non-
Hispanic whites, 2,108 non-Hispanic blacks, and 2,073 Mexican
Americans. As expected[27], the mean Lp(a) level in non-Hispanic
blacks was 43.4 mg/dL (SD, 32.8 mg/dL), a twofold increase
compared to non-Hispanic whites and a three-fold increase
compared to Mexican Americans. Mexican Americans had
significantly lower mean Lp(a) levels compared to whites
(p,0.0001). Body mass index (BMI) was similar across all three
populations (p=0.093). Demographic variables age and sex, along
with other blood lipid traits LDL-C, HDL-C, and triglycerides,
differed significantly (p,0.0001) across populations.
TagSNP allele frequencies are presented in Supplementary
Table S1, by population. We calculated the Pearson correlation
coefficient (r) between each of the three populations. Not
surprisingly[28,29], LPA allele frequencies observed in non-
Hispanic whites were highly correlated with allele frequencies
observed in Mexican Americans (r=0.80). Also as expected[28–
30], we observed weaker correlation between allele frequencies in
non-Hispanic blacks compared with non-Hispanic whites (r=0.60)
and Mexican Americans (r=0.48). Furthermore, compared with
non-Hispanic whites, the proportion of SNPs that differed in allele
frequency by more than 60.10 was smaller in Mexican Americans
(2/19 SNPs; 11%) than in blacks (11/19 SNPs; 58%).
We also compared the allele frequencies of these LPA SNPs in
NHANES III to those in HapMap[31,32] (Supplementary Table
S2). Among the 12 LPA SNPs that overlapped this dataset and
HapMap, we observed extremely high correlations (r$0.99) in
allele frequencies between non-Hispanic whites and HapMap
CEU (US individuals of northern and western European ancestry)
and between non-Hispanic blacks and both HapMap YRI
(Yoruba from West Africa) and ASW (individuals with African
ancestry from the Southwest USA). Mexican American allele
frequencies were also very similar (r=0.93) to those of HapMap
MEX (individuals with Mexican ancestry in Los Angeles,
California). Because Mexican Americans are a historically
admixed population, a comparison with HapMap Asian popula-
tions was performed. The correlation between NHANES Mexican
Americans and HapMap Han Chinese (HCB) and Japanese (JPT)
was 0.77 and 0.78, respectively.
Haplotype frequencies were inferred for the 19 tagSNPs in LPA
by NHANES III subpopulation. We observed eight common
haplotypes (frequency .5%) in at least one subpopulation
(Supplementary Table S3). While two haplotypes (#1 and #2)
were common across all three populations, the remaining
haplotypes were either common only to non-Hispanic blacks
(#7 and #8), only non-Hispanic whites (#6), or shared between
whites and Mexican Americans (#3, #4, #5). As expected[33],
the majority of chromosomes from non-Hispanic whites (71.5%)
and Mexican Americans (72.6%) were represented by common
haplotypes inferred from LPA tagSNPs. Only approximately half
of the chromosomes from non-Hispanics blacks (55.7%) were
represented by common haplotypes, and the remaining half are
scattered across rare haplotypes.
Table 1. NHANES III study population characteristics.
Variable
Non-Hispanic Whites
(n=2,631)
Non-Hispanic Blacks
(n=2,108)
Mexican Americans
(n=2,073) P-value
Males, % 40.0% 42.6% 49.4% ,0.0001
Age (yr) 50.2 (22.3) 36.0 (18.3) 37.1 (18.7) ,0.0001
BMI (kg/m
2) 26.3 (5.6) 27.3 (6.8) 27.0 (5.6) 0.093
Lp(a) (mg/dL) 20.3 (24.1) 43.4 (32.8) 14.9 (8.5) ,0.0001
HDL-C (mg/dL) 50.2 (15.6) 53.8 (16.4) 48.0 (13.1) 0.112
LDL-C (mg/dL) 127.0 (38.0) 118.8 (39.5) 116.3 (34.1) ,0.0001
TG (mg/dL) 147.63 (116.8) 108.8 (79.9) 154.1 (121.2) ,0.0001
Study characteristics are shown for participants greater than 18 years of age who had non-missing Lp(a) levels. Samples sizes shown are the DNA samples available in
Genetic NHANES III for each subpopulation. Values are shown as unweighted mean (SD). BMI, body mass index; Lp(a), lipoprotein(a); HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides. P-values are based on one-way unweighted ANOVA.
doi:10.1371/journal.pone.0016604.t001
LPA and Lp(a) in NHANES III
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Each SNP was tested for an association with transformed Lp(a)
levels. Results from this analysis are presented in Figure 1 and
Table 2. After adjusting for age and sex, 15 of the 19 SNPs tested
were significantly associated with Lp(a) levels in at least one
subpopulation at p,0.0001, meeting the standard Bonferroni p-
value threshold for multiple testing. Among non-Hispanic whites,
we confirmed previous evidence of a strong association with
rs6919346 (p=1.2610
230)[22,24], which explained approximate-
ly 6% of the trait variance (R
2=0.057) in our dataset. We also
identified two novel associations with rs6926458 and rs12194138
(p=5.3610
26 and 2.1610
213, respectively). To evaluate the
combined effects of significantly associated variants, we calculated
a continuous Genetic Risk Score (GRS) for each participant based
on his or her total number of risk (i.e. Lp(a) increasing) alleles at
each associated SNP. Based on the GRS, the additive effect of
rs6919646, rs6926458, and rs12194138 explained 7% of the
variation in transformed Lp(a) levels in non-Hispanic whites
(Table 3).
Mexican Americans had twice the number of significant
associations compared with non-Hispanic whites, with six SNPs
associated with transformed Lp(a) levels at p,0.0001. One SNP in
particular, rs1652507, was strongly associated at p=5.44610
234
and had the largest effect size of all the associations (R
2=0.086).
Two of the six associated SNPs (rs1321195 and rs7765803) have
previously been associated with Lp(a) in a cohort of Europe-
ans[22]. The joint effect of all six associated SNPs, as measured by
the GRS, explained 11% of the variance in Lp(a) trait distribution
observed in Mexican Americans.
Of the three subpopulations, non-Hispanic blacks had the
greatest number of significant associations at p,0.0001 with 12
SNPs. Each associated SNP contributed 1% to 4.5% of the trait
variance, with the additive effect of the SNPs contributing up to
9% of the total variance in Lp(a) levels. Five of the 12 associated
SNPs (rs1321195, rs1652507, rs6919346, rs6926458, and
rs7755463) were also associated in one of the two other racial/
ethnic groups, non-Hispanic whites or Mexican Americans, and
the directions of the effect (beta) were consistent across the
associated subpopulations.
LPA risk allele distribution
The proportion of risk alleles (i.e. the total number of risk alleles
divided by the number of risk alleles possible) was examined across
all NHANES subpopulations (Figure 2). In general, the distribu-
tions differed greatly among non-Hispanic whites, non-Hispanic
blacks, and Mexican Americans. In non-Hispanic whites, the
Figure 1. Overview of association results between LPA SNPs and Lp(a) levels. Plot showing the significance of all single-SNP associations
with transformed Lp(a) levels. All results are unweighted adjusted for age and sex and are stratified by race/ethnicity. SNPs are plotted on top along
the x axis in order from 59 to 39, and association with Lp(a) is indicated on the y axis (as 2log10 p-value). Red line indicates p-value of 1610
24.
Direction of the triangle indicates direction of effect (b-coefficient).
doi:10.1371/journal.pone.0016604.g001
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SNPs
Non-Hispanic Whites
n=2,397
Non-Hispanic Blacks
n=1,711
Mexican Americans
n=1,749
b
(95% CI) R
2 P-value
b
(95% CI) R
2 P-value
b
(95% CI) R
2 P-value
rs1321196 20.13
(20.22, 20.05)
0.0036 0.0026 0.21
(0.14, 0.28)
0.0193 1.88610
28 0.12
(0.02, 0.22)
0.0031 0.0204
rs1321195 0.05
(20.07, 0.18)
0.0003 0.3863 0.53
(0.31, 0.75)
0.0123 3.03610
26 0.40
(0.23, 0.56)
0.0127 3.49610
26
rs1367211 20.004
(20.10, 0.09)
0.0000 0.9330 20.27
(20.34, 20.20)
0.0345 3.67610
214 20.15
(20.26, 0.04)
0.0039 0.0092
rs1652507 20.05
(20.16, 0.05)
0.0005 0.3295 20.45
(20.59, 20.32)
0.0247 1.06610
210 20.54
(20.63, 20.46)
0.0858 5.44610
234
rs6907156 0.21
(20.51, 0.92)
0.0001 0.5722 0.15
(0.05, 0.25)
0.0053 0.0031 0.73
(0.39, 1.06)
0.0103 2.14610
25
rs6919346 0.61
(0.51, 0.71)
0.0565 1.18610
230 0.75
(0.56, 0.94)
0.0344 2.16610
214 0.18
(0.02, 0.33)
0.0029 0.0248
rs6926458 20.23
(20.32, 20.13)
0.0087 5.29610
26 20.45
(20.57, 20.34)
0.0364 5.90610
215 20.15
(20.28, 0.03)
0.0032 0.0189
rs7755463 20.47
(20.99, 0.06)
0.0014 0.0823 20.33
(20.40, 20.25)
0.0449 4.01610
218 20.89
(21.16. 20.62)
0.0230 2.14610
210
rs7767084 0.07
(20.05, 0.18)
0.0006 0.2467 20.41
(20.61, 20.21)
0.0097 5.88610
25 0.10
(20.03, 0.23)
0.0015 0.1187
rs9364564 0.19
(0.08, 0.29)
0.0049 0.0007 0.33
(0.21, 0.46)
0.0156 2.29610
27 0.11
(20.02, 0.24)
0.0016 0.1053
rs12212507 0.03
(20.15, 0.21)
0.0001 0.7633 0.63
(0.23, 1.03)
0.0063 0.0019 0.57
(0.14, 1.00)
0.0037 0.0093
rs13192132 20.14
(20.23, 20.06)
0.0043 0.0011 20.43
(20.53, 20.33)
0.0425 3.85610
217 20.003
(20.11, 0.10)
0.0000 0.9508
rs10945682 0.12
(0.04, 0.21)
0.0033 0.0041 20.14
(20.21, 20.06)
0.0079 0.0003 20.16
(20.26, 20.06)
0.0055 0.0022
rs12194138 20.41
(20.52, 20.30)
0.0229 2.05610
213 0.34
(0.12, 0.56)
0.0020 0.0014 20.47
(20.66, 20.28)
0.0149 7.97610
27
rs7450261 0.10
(21.29, 1.48)
0.0000 0.8907 0.35
(0.18, 0.51)
0.0108 2.84610
25 20.33
(21.34, 0.68)
0.0003 0.5176
rs7450411 0.19
(0.08, 0.30)
0.0051 0.0005 0.37
(0.27, 0.47)
0.0308 7.37610
213 0.12
(20.02, 0.25)
0.0017 0.0910
rs7765803 20.05
(20.14, 0.04)
0.0005 0.2471 0.13
(0.06, 0.20)
0.0071 0.0005 0.21
(0.10, 0.31)
0.0089 8.54610
25
rs41265936 20.80
(22.04, 0.44)
0.0007 0.2037 20.22
(20.37, 20.06)
0.0047 0.0054 20.88
(21.48, 20.28)
0.0046 0.0039
rs41271028 20.45
(21.22, 0.32)
0.0006 0.2556 20.06
(20.18, 0.07)
0.0007 0.3608 20.66
(21.06, 20.27)
0.0061 0.0011
The association of LPA SNPs with log transformed Lp(a) levels is shown by a regression coefficient (beta, b) and 95% confidence interval (CI) for each SNP, adjusted for
age and sex. Measures of variance explained (R
2) are provided for each SNP based on unadjusted regressions. Significant associations (P-value,0.0001) are in bold.
doi:10.1371/journal.pone.0016604.t002
Table 3. Additive effects of LPA risk alleles on Lp(a) levels.
Non-Hispanic Whites Non-Hispanic Blacks Mexican Americans
Total n 2269 1605 1665
No. SNPs used in GRS 3 12 6
b (95% CI) 0.36 (0.31–0.42) 0.11 (0.09–0.13) 0.34 (0.29–0.39)
P-value ,10
235 ,10
234 ,10
241
R
2 0.07 0.09 0.11
The amount of variance explained (R
2) in transformed Lp(a) levels by the Genetic Risk Score (GRS) is displayed, along with the regression coefficient (beta, b) and 95%
confidence interval (CI) for each association.
doi:10.1371/journal.pone.0016604.t003
LPA and Lp(a) in NHANES III
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average (mean) number of risk alleles was 3.5 out of the possible six
risk alleles (58.3%). In contrast, the distribution of risk alleles was
skewed to the left in non-Hispanic blacks and to the right in
Mexican Americans (Figure 2). The average number of risk alleles
in non-Hispanic black participants was 17 out of 24 possible risk
alleles (70.8%) while the average number in Mexican American
participants was 5.5 out of the 12 possible risk alleles (45.8%).
Overall, non-Hispanic blacks had the largest genetic burden of all
three subpopulations defined by these alleles, with 99.0% percent
of participants possessing greater than 50% of the possible risk
alleles. This genetic burden is significantly greater than that
carried by non-Hispanic whites (51.4%, p,0.001) or Mexican
Americans (2.7%, p,0.001). Figure 2 also illustrates mean Lp(a)
levels in participants with various proportions of risk alleles. As
expected, mean Lp(a) is higher in participants with a greater
proportion of risk alleles, again reflecting the role that these
variants may play in contributing to both between- and within-
population Lp(a) trait variation.
Discussion
In this study, we identified several variants in the LPA gene that
are strongly associated with Lp(a) levels in a diverse epidemiologic
study. More specifically, three SNPs in non-Hispanic whites,
twelve SNPs in non-Hispanic blacks, and six SNPs in Mexican
Americans were strongly associated at p,0.0001. While no single
LPA variant was significantly associated in all three racial/ethnic
groups, six SNPs were significantly associated in two subpopula-
tions and the directions of effects were consistent.
Most previously published studies characterizing the relation-
ship between Lp(a) and LPA have focused on the effects of the
kringle IV-2 copy number polymorphism. More recently, a
genome-wide association study in Hutterites identified one SNP
in LPA (rs6919346) that associated with Lp(a) levels, independent
of kringle IV-2 copy number[24]. Subsequent studies have found
this variant to be independently associated with increased Lp(a)
levels in European Caucasians[22,23] and South Asians and
Chinese[23]. In our study, the same allele (G) was also strongly
associated with increased trait levels not only in non-Hispanic
whites (b=0.61, p=1.18610
230) but also in non-Hispanic blacks
(b=0.75, p=2.16610
214). In contrast, the association in Mexican
Americans was much less robust (p=0.02), but the effect trended
in the same direction (b=0.18). This intronic tagSNP is not in
linkage disequilibrium (LD) with any genotyped SNP (Supple-
mentary Figure S1), nor with the kringle IV repeat[25]. As others
have suggested[24], rs6919346 may be tagging the causal variant
or, due to the fact that it resides in a CRE-binding site, may play a
role in gene expression.
It is interesting to note that while we did replicate the
association between Lp(a) levels and rs6919346, we did not
necessarily replicate the associations reported recently for
rs10945682 and rs7765803[23]. LPA rs10945682 was not
associated with Lp(a) levels in NHANES III at the significant
threshold of p,0.0001 (Table 2). Furthermore, while the direction
of effect in non-Hispanic whites was consistent with that observed
for Europeans and Asians studied by Lanktree et al (taking into
account the coded allele), the direction of effect was opposite in the
non-Hispanic black and Mexican American subpopulations in
NHANES III. LPA rs7765803 was not associated with Lp(a) levels
in non-Hispanic whites (p=0.2471) while it was strongly
associated in European and Asian populations in Lanktree et al.
Finally, the data reported here are not consistent with the linkage
disequilibrium data reported by Lanktree et al. LPA rs10945682
and rs6919346 are reported to be in the same linkage
disequilibrium block[23] but the LD calculated in our non-
Hispanic white samples and in HapMap CEU suggests there is
little LD (r
2=0.06 and 0.03 in non-Hispanic whites and CEU,
respectively) between the two SNPs. It is possible that this
discrepancy can be explained by unidentified population sub-
structure or by the use of different LD measures, but this is unclear
from the literature and requires further investigation.
As alluded to above, the relationship between LPA tagSNPs and
Lp(a) levels may represent a direct (i.e. causal) or indirect (i.e.
Figure 2. Distribution of LPA risk alleles in non-Hispanic whites,
non-Hispanic blacks, and Mexican Americans. Plots showing the
frequency distributions of the proportion of risk alleles in the three
NHANES III subpopulations. Proportion of risk alleles was calculated by
dividing the total number of LPA risk alleles (i.e. the GRS, see Materials
and Methods) by the total number of possible risk alleles in each
population, multiplied by 100%. Mean Lp(a) values are also plotted for
each corresponding proportion.
doi:10.1371/journal.pone.0016604.g002
LPA and Lp(a) in NHANES III
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most likely applies to the majority of SNPs genotyped in this study.
Of the 19 LPA SNPs, 17 are located in introns, and the two
nonsynonymous SNPs (rs7765803 and rs41265936, Supplemen-
tary Table S1) are not predicted to alter protein function using
SIFT[34]. Additional studies are needed to determine if these
variants regulate LPA expression in vivo. However, since apo(a) is
present only in humans, Old World primates, and the hedgehog,
resources for these studies are limited to transgenic mice and
rabbits as models[35].
In an attempt to evaluate the joint effect of significantly
associated variants, a genetic risk score (GRS) was calculated.
Based on this GRS, these variants together explained 7%, 9%, and
11% of the variance in Lp(a) levels in non-Hispanic whites, non-
Hispanic blacks, and Mexican Americans, respectively. In
comparison to the effect attributed to the kringle repeat region
based on previous studies[15,16,20,21,28,36–38], the effect of
these SNPs is considerably small.
This study has several strengths and limitations. The greatest
strength is the use of a large and diverse population. While there
have been several studies of LPA SNPs and its association with
Lp(a) that have included both European and African descent
populations, no single study, to our knowledge, has also included
Mexican Americans genotyped for the same LPA SNPs. This latter
point cannot be under emphasized as the Hispanic or Latino
population is the fastest growing minority population in the United
States yet remains relatively underrepresented in genetic associ-
ation studies[39].
A limitation is that the method of measuring serum Lp(a) levels
in NHANES III does not account for apo(a) isoform size. While
accurate measurement of apo(a) isoform is ideal, the reliability of
the Lp(a) measurement used here has been adequately demon-
strated[26]. Furthermore, there is no generally accepted labora-
tory procedure or national standardization program for Lp(a)
measurement, which may help to explain the lack of general-
izabilty across studies[14].
A second major limitation is that NHANES III does not have
data on kringle repeat size for each participant. Several methods
are used to measure kringle repeat size such as Southern blot[28]
and quantitative PCR[40], neither of which can be used in
NHANES III DNA samples given investigators are aliquoted
limited amounts of DNA from crude cell lysates. Without these
data, it is unclear if the associations between LPA SNPs and Lp(a)
levels reported here are independent of the KIV-2 copy number
variant, which has a well-established, large effect on Lp(a) levels.
The amount of linkage disequilibrium, or lack thereof, between
the KIV-2 region and other LPA variants is a controversial issue.
Previous studies have reported strong LD between the KIV-2
alleles and SNPs in or around LPA[22,41–43]. In contrast,
additional studies indicate the lack of strong LD[24,28]. More
specifically, the tagSNPs genotyped in this study had been selected
from a previous study[28] that provided data on kringle IV-2
repeat size, and no strong LD (r
2.0.80) was found for any of the
SNPs tested[28]. However, there was moderate LD (r
2=0.45 in
European American and r
2=0.57 in African American samples)
between kringle repeat sizes 10 and 14 and LPA SNPs 74970 and
rs41271028, respectively[28]. LPA 74970 was not genotyped here.
LPA rs41271028 was genotyped here but was not significantly
associated with Lp(a) levels in any of the three subpopulations after
correction for multiple testing (Table 2). Thus, the tagSNPs
genotyped here and significantly associated with Lp(a) levels after
correction for multiple testing are not in high or moderate LD with
specific kringle repeat sizes examined in the original dataset
reported by Crawford et al[28]. Further studies are needed in
NHANES and other large datasets to characterize the full
spectrum of LPA genetic variation and its impact on Lp(a) levels
in diverse populations.
Another limitation of this study is that only approximately 30–
35% of the LDSelect ‘‘bins’’ for European Americans and African
Americans are represented by tagSNPs as many LPA SNPs failed
assay design or genotyping in NHANES III. And, tagSNPs
selection was limited to common variation, leaving rarer variation
such as LPA rs10455872 (,5% MAF) untested. Thus, much of the
genetic variation in LPA and its association with Lp(a) levels in
these populations remains to be explored. Furthermore, tagSNPs
were not selected specifically for the Mexican American
subpopulation. At the time of tagSNPs selection, HapMap 3
Mexican American samples were not available at the time, and it
was unclear which populations should be used for tagSNPs
selection to adequately represent this admixed population. It is
important to note that, however, that while our tagSNPs selection
process may have been biased for populations of European- and
African-descent, the allele frequencies observed in NHANES III
Mexican Americans were very similar to that of non-Hispanic
whites. Furthermore, our lack of Mexican American specific
tagSNPs does not undermine the observation that there is an
excess of significant variants associated only in non-Hispanic
blacks compared to non-Hispanic whites.
Because of these strengths, and despite these limitations, we
have taken an important step in understanding how LPA genetic
variants contribute to Lp(a) levels in a diverse population. One of
the major findings of our study was that there were notably more
significant associations between Lp(a) and LPA SNPs in non-
Hispanic blacks compared to non-Hispanic whites and Mexican
Americans. Moreover, nearly half of these associations were
exclusive to non-Hispanic blacks. Our results suggest that
between-population differences in Lp(a) levels can be explained,
in part, by multiple population-specific cis-acting variants in LPA.
While the role of multiple trans-acting factors in Lp(a) trait
distribution has been disputed[44–46] and cannot be ruled out,
our results reaffirm the need for more comprehensive studies of the
effects of LPA variants in large, diverse populations.
Materials and Methods
Ethics Statement
All procedures were approved by the CDC Ethics Review
Board and written informed consent was obtained from all
participants. This candidate gene association study was approved
by the CDC Ethics Review Board (protocols #2003-08 and
#2006-11) and the University of Washington’s Institutional
Review Board (IRB #23667; HSRC D committee). Because no
identifying information was accessed by the investigators, this
study was considered exempt from Human Subjects by Vanderbilt
University’s Institutional Review Board (IRB #061062; HS2
committee).
Study Population
Ascertainment of the Third National Health and Nutrition
Examination Survey (NHANES III) and method of DNA collection
have been previously described[47–49] and so will only be briefly
described here. The National Health and Nutrition Examination
Surveys are cross-sectional surveys conducted by the National
Center for Health Statistics (NCHS) at the Centers for Disease
Control and Prevention (CDC). NHANES III was conducted
between 1988–1990(phase1)and 1991–1994(phase2)[50,51].Like
all the NHANES, NHANES III is a complex survey design that
over-sampled minorities (non-Hispanic blacks and Mexican Amer-
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that collect demographic, socioeconomic, dietary, and health-
related data. Also, all NHANES study participants undergo a
detailed medical examination at a central location known as the
Mobile Examination Center (MEC). The medical examination
includes the collection of physiological measurements by CDC
medical personnel and blood and urine samples for laboratory tests.
Beginning with phase 2 of NHANES III, DNA samples were
collected from study participants aged 12 years and older.
Laboratory Measures
Serum total cholesterol, triglycerides, and HDL cholesterol were
measured using standard enzymatic methods. LDL cholesterol was
calculated using the Friedewald equation, with missing values
assigned for samples with triglyceride levels greater than 400 mg/
dl. Serum Lp(a) levels were measured immunochemically by
enzyme-linked immunosorbant assay (ELISA) (Strategic Diagnos-
tics, Newark, DE), which does not have cross reactivity with
plasminogen or LDL and is non-sensitive to apo(a) size
heterogeneity[26]. Quality control measures of the Lp(a) assay
have been described elsewhere and the reliability of this Lp(a)
measurement has been adequately demonstrated [26].
SNP Selection and Genotyping
Single nucleotide polymorphisms (SNPs) were selected from
SeattleSNPs data on European Americans (n=23) and African
Americans (n=24) re-sequenced for SNP discovery as previously
described[25]. Briefly, tagSNPs were chosen for genotyping in
both populations separately using LDSelect[52] at minor allele
frequency (MAF) .5% and r
2.0.80. At the time of tagSNPs
selection (2006), LPA variation data was not available for Mexican
Americans or other Hispanic reference samples. Forty-nine SNPs
were considered for genotyping, 35 SNPs were targeted for
genotyping, and 20 were successfully genotyped. Genotyping was
performed using the Illumina GoldenGate assay (as part of a
custom 384 OPA) by the Center for Inherited Disease Research
(CIDR) through the National Heart Lung and Blood Institute’s
Resequencing and Genotyping Service. A display of the
chromosomal locations of all 20 LPA SNPs, along with their
relative locations to the 59 untranslated region (represented by
rs1800769) and the kringle repeat (represented by rs9457952 and
rs9457986, which flank the kringle repeat), is presented in
Supplementary Figure S2.
Genotyping call rates and tests of Hardy Weinberg Equilibrium
stratified by self-reported race/ethnicity were calculated for all
genotyped LPA SNPs (Supplementary Table S1). The average
genotyping call rate for all 20 SNPs was 95.9%. SNP rs4073498
was out of Hardy Weinberg Equilibrium (HWE; p,0.01) in all
three racial/ethnic groups and was therefore excluded from all
analyses as mandated by CDC. Five additional SNPs (rs1321195,
rs1652507, rs7755463, rs7450261, and rs41265936) were found to
be out HWE in one subpopulation but were carried forward in the
analysis. In addition to these quality control metrics, we genotyped
blinded duplicates as required by CDC, and all SNPs reported
here passed quality control metrics required by CDC. All genotype
data reported here were deposited into the NHANES III Genetic
database and are available for secondary analysis through CDC.
Statistical Methods
Analyses were performed for each self-reported race/ethnicity
separately. Quality control measures were implemented in
PLINK[53]. Tests of association were performed using SAS
version 9.1 and were limited to participants greater than 18 years
of age who had non-missing Lp(a) levels regardless of fasting status.
Each genetic variant was tested for association with ln(Lp(a)+1)
levels (a transformation that approximated normality) using linear
regression assuming an additive genetic model. Analyses were
performed adjusted for age and sex, and results were plotted using
Synthesis-View[54,55]. Data were accessed remotely from the
CDC’s Research Data Center (RDC) in Hyattsville, Maryland
using Analytic Data Research by Email (ANDRE). Statistical
significance was defined as p,0.0001, which represents the
Bonferroni corrected p-value [p=0.0008=0.05/(20 SNPs 6 3
populations)]. Using STATA 10.1, the frequency of risk alleles was
compared between populations using Pearson’s chi-squared test.
Pair-wise linkage disequilibrium (r
2) was calculated using the
Genome Variation Server provided by SeattleSNPs (http://gvs.gs.
washington.edu/GVS/). Haplotypes were inferred by SAS/
Genetics using the expectation-maximization algorithm in each
subpopulation separately.
To account for selection and non-response biases, the National
Center for Health Statistics provides a weighting methodology,
which has been described elsewhere[56]. We performed tests of
association both unweighted (using SAS version 9.1) and weighted
(using SUDAAN). The results did not differ appreciably; therefore,
unweighted results are presented here and only select weighted
results are presented in Supplementary Table S4.
Genetic Risk Score Calculation
The Genetic Risk Score (GRS) was calculated for every
participant, respective to each population separately, using SNPs
that were associated with transformed Lp(a) levels at p,0.0001. We
used a count method and assumed each SNP to be independently
associated with increased levels of Lp(a). Assuming an additive
genetic model for each SNP, a value of 2 was given to individuals
who were homozygous for the ‘‘risk’’ allele (i.e. the allele associated
with increased levels of transformed Lp(a) levels). Values of 1 and 0
were given to genotypes containing 1 or 0 copies of the risk allele,
respectively. The GRS was calculated summing the number of risk
alleles at each locus. Participants with incomplete genotype data at
any SNP used in the GRS were excluded from analysis. Linear
regression, with continuous GRS as the independent variable, was
used to evaluate the joint effects (R
2) of associated genetic variants
for Lp(a) trait variation. A weighted GRS (WGRS) was also
calculated by multiplying each b-coefficient from adjusted tests of
association by the number of risk alleles, and then summing the
products. Compared to the GRS, the results of the WGRS do not
appreciably differ (Supplementary Table S5); therefore, GRS was
used for the main analyses in the paper.
Supporting Information
Figure S1 Pair-wise linkage disequilibrium (r
2) calcu-
lated for 19 LPA SNPs in non-Hispanic whites (A), non-
Hispanic blacks (B), and Mexican Americans (C) in
NHANES III.
(DOC)
Figure S2 Location of genotyped LPA SNPs relative to
the kringle repeat region and a SNP in the 59 untrans-
lated region. Synthesis-View[1] was used to plot the 20 LPA
SNPs genotyped in this study. Three other SNPs not genotyped in
this study are also represented in this plot within the boxes:
rs1800769 (which represents a 59 UTR SNP genotyped by
Rainwater et al 1997[2]) and rs9457986 and rs9457952, which
flank the kringle repeat. Chromosomal locations are based on
genome build 36.
(DOC)
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metrics, stratified by race/ethnicity.
(DOC)
Table S2 Frequency of LPA variants in HapMap
samples.
(DOC)
Table S3 LPA common haplotypes and haplotype
frequencies. Only haplotypes with frequencies .5% in at least
one population are displayed. Alleles are ordered based on
chromosomal location (59 to 39). Frequencies .5% are in bold.
(DOC)
Table S4 Associations between LPA SNPs and Lp(a)
levels, weighted for selection and non-response biases.
The association of LPA SNPs with log transformed Lp(a) levels is
shown by a regression coefficient (beta, b) and 95% confidence
interval (CI) for each SNP, adjusted for age and sex. Measures of
variance explained (R
2) are provided for each SNP based on
unadjusted regressions. Significant associations (P-value,0.0001)
are in bold.
(DOC)
Table S5 Additive effects of LPA alleles associated with
increased Lp(a) levels. The amount of variance explained (R
2)
in transformed Lp(a) levels by the Weighted Genetic Risk Score
(WGRS) is displayed, along with the median WGRS score,
WGRS interquartile range (IQR), regression coefficient (beta, b)
and 95% confidence interval (CI) for each association.
(DOC)
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